BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OTRADI - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.otradi.org
X-WR-CALDESC:Events for OTRADI
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210727T120000
DTEND;TZID=America/Los_Angeles:20210727T130000
DTSTAMP:20210621T234641Z
CREATED:20210423T222807Z
LAST-MODIFIED:20210621T234641Z
UID:10000335-1627387200-1627390800@www.otradi.org
SUMMARY:Virtual Lunch & Learn: Accelerating Global Pharma Licensing and Financing
DESCRIPTION:Biotech startups – are you looking to raise private financing\, or seeking regional or global licensing deals? \nThis virtual Lunch & Learn is for anyone who is seeking to raise a private financing round\, or seeking a regional or global licensing deal for a preclinical-stage program\, clinical-stage program\, or technology. \nLicensing is one of the most common collaborations in the life-science industry and licensing cash flows are also a significant source of non-dilutive financing. However\, how to effectively license-in/out an asset can be one of the obstacles\, as these require connections and experiences. In this presentation\, Gemseki will share the know-how of licensing and its Drug Candidate Marketplace with the audience. \nRegister now! \nAbout the Speaker:\nSanjeev Balhara is a Vice President for Business Development of Gemseki. \nFrom 2008 to 2018\, Sanjeev worked as Chief Investment Officer and VP Corporate Development at Ignyta\, an oncology company (NASDAQ: RXDX)\, and as Vice President at Third Security\, a life sciences venture capital firm with assets of $2B AUM. He participated in search and evaluation of licensing\, merger and acquisition opportunities in biotech and pharma. Some of the BD activities that Sanjeev participated in include the sale of Clinical Data to Forest for $1.2B\, sale of genomic tests business to Transgenomics for $15 million\, acquisition of pipeline drugs from Teva for $15M stock\, acquisition of a pipeline drug from Eli Lilly for $2M cash and $12M stock\, and $100M+ in follow-on investments in Intrexon\, Clinical Data and Halozyme. \nHe has a Bachelor in Electrical Engineering degree from the Indian Institute of Technology\, Varanasi\, India and an MBA from the Wharton School\, University of Pennsylvania. \nThank you to our sponsor\, Gemseki. \nFounded in 2017\, Gemseki is a Tokyo-based company with multinational members worldwide specializing in business development and licensing for the bio-industry. Recently\, we successfully facilitated an international industry-academia collaboration between Harvard and Kyowa Kirin. With more than 300 assets listed\, Gemseki’s ‘Drug Candidate Marketplace’ serves as a digital platform to connect the licensing partners to accelerate drug developments and the platform is widely used by visitors from 100+ countries. \nRegister here.
URL:https://www.otradi.org/event/lunch-learn-global-biopharma-partnering/
LOCATION:OR\, United States
CATEGORIES:OBI Programs/Events
END:VEVENT
END:VCALENDAR